Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience-Reference-Cited by-同舟云学术

Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience

Published:2019-05 Issue:5 Volume:14 Page:876-889
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

El Osta Badi,Behera Madhusmita,Kim Sungjin,Berry Lynne D.,Sica Gabriel,Pillai Rathi N.,Owonikoko Taofeek K.,Kris Mark G.,Johnson Bruce E.,Kwiatkowski David J.,Sholl Lynette M.,Aisner Dara L.,Bunn Paul A.,Khuri Fadlo R.,Ramalingam Suresh S.

Funder

National Cancer Research Institute

Winship Cancer Institute

Free To Breathe

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference33 articles.

1. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas;Campbell;Nat Genet,2016

2. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non–small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial;Rosell;Lancet Oncol,2012

3. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer;Shaw;N Engl J Med,2013

4. Crizotinib in ROS1-rearranged non–small-cell lung cancer;Shaw;N Engl J Med,2014

5. Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non–small cell lung cancer: an open-label, multicentre phase 2 trial;Planchard;Lancet Oncol,2016

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics of KRAS mutation subtypes in non-small cell lung cancer population in Xinjiang, China, and their impact on the prognosis of immunotherapy;Journal of Cancer Research and Clinical Oncology;2024-09-07

2. Current perspectives of KRAS in non-small cell lung cancer;Current Problems in Cancer;2024-08

3. Drug development and evidence for lung cancer targeted therapy in Eastern Asia;The Lancet Regional Health - Western Pacific;2024-08

4. Remote organ cancer adversely alters renal function and induces kidney injury, inflammation, and fibrosis;2024-07-30

5. Lymph node metastasis in early invasive lung adenocarcinoma: Prediction model establishment and validation based on genomic profiling and clinicopathologic characteristics;Cancer Medicine;2024-07